dazoxiben has been researched along with prostaglandin f1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ennis, C; Granger, SE; Middlefell, VC; Philpot, ME; Shepperson, NB | 1 |
| Everitt, J; Ferro, TJ; Johnson, A; Malik, AB | 1 |
2 other study(ies) available for dazoxiben and prostaglandin f1
| Article | Year |
|---|---|
Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Nitrendipine; Prostaglandins F; Rats; Rats, Inbred SHR; Thromboxane B2; Thromboxane-A Synthase | 1989 |
IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes.
Topics: Animals; Capillary Permeability; Endothelium, Vascular; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Organ Size; Papaverine; Prostaglandins F; Pulmonary Edema; Pulmonary Wedge Pressure; Serum Albumin, Radio-Iodinated; Thromboxane B2; Vasoconstriction | 1989 |